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Background: Cardiac function measured as the oxygen pulse (O2 pulse) is impaired during exer-
cise (CPET) in patients with COPD. We investigated the relationship between handgrip force
and O2 pulse in COPD and controls.
Methods: We measured anthropometrics, lung function, respiratory muscle force, handgrip
(HG) force and fat free mass (FFM) at rest in 18 men with COPD (FEV1 % Z 45  20) and 15
controls. We then performed a symptom limited cardiopulmonary exercise test (CPET) with
similar load and used heart rate, and oxygen pulse (VO2/HR) to express cardiac function at rest
and during exercise. We corrected the O2 pulse by FFM.
Results: Patients and controls were similar in BMI and FFM. COPD patients had lower handgrip
(37.8  7 vs. 55  2) kg. O2 pulse and HG were associated (rZ 0.665). At rest, COPD patients
had faster heart rate (76  11 vs. 61  5) and lower oxygen pulse. COPD patients had lower
oxygen pulse mL/beat at exercise isotime (10.6  3.7 vs. 14.3  2.7), even adjusted by muscle
mass.
Conclusion: Handgrip is associated with impaired heart function at rest and during exercise in
COPD patients even adjusting for muscle mass differences. Lower handgrip may be a marker of
impaired cardiac function in COPD patients.
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Impairedexercise tolerance is common inpatientswithCOPD.
The reasons for this limitation are multiple and include:
alterations in pulmonary mechanics, dysfunction of the
respiratory muscles, dynamic hyperinflation, abnormal gas
exchange and development of dyspnea.1,2 In some patients,
abnormal peripheral muscle function is also thought to play
a significant role in exercise limitation. The possible contri-
bution of cardiovascular factors to exercise limitation in
patients with COPD is less well characterized but is receiving
increasing attention.3e5
The interactions between lung mechanics and heart func-
tion in patients with COPD have received significant
attention.6e8 Whether the mechanism is due to changes in
cardiac afterload or preload, all of the studies agree that the
swings in intra-thoracic pressure are important in determining
heart function in patients with COPD.3e5 In a recent epide-
miological study, Barr et al.6 reported an association between
the presence of emphysema and decreased stroke volume in
patients with airflow obstruction, but most subjects had
minimal airflow limitation and were unlikely to have signifi-
cant hyperinflation. No precise mechanisms were studied but
the results suggest that factors other than hyperinflation may
play a role in explaining the association between COPD and
decreased heart function. We have shown that cardiac func-
tion measured as the oxygen pulse (O2 pulse), a reliable index
of stroke volume in patients with COPD, was impaired during
exerciseandwas inpart related to lunghyperinflation.3 In that
study we also observed that handgrip strength was strongly
associated with O2 pulse, independent of the degree of lung
hyperinflation.
Handgrip measurement is a reliable marker of peripheral
muscle strength. It has been associated with poor functional
capacity and mortality in population studies.7 Further, in
patients with congestive heart failure and without COPD, an
association between handgrip force, exercise capacity and
survival has been recently reported.8 Patientswith COPD and
those with chronic heart failure (CHF) present many simi-
larities with respect to peripheral muscle dysfunction. In
both diseases there is loss of fat freemass (FFM) and reduced
daily activity level as well as exercise capacity when
compared to age-matched healthy control subjects. In both
disorders there is generalized peripheral muscle weakness.
Furthermore, FFM is a stronger predictor of exercise
capacity9 than common indices such as the FEV1 in COPD or
left ventricular ejection fraction in CHF.10
The interaction of impaired cardiac function and hand-
grip strength and their relation to exercise tolerance in
COPD patients has not been studied. Thus, we designed this
prospective study to investigate the relationship between
handgrip force at rest and cardiac function at rest and
during exercise in stable male patients with COPD. Further,
we explored whether the association persisted independent
of overall muscle mass. To avoid the effect of gender on
muscle mass, we selected only men for this study.
Methods
We studied 18 consecutive male patients with moderate to
severe COPD and 15 controls of similar age at St Elizabeth’sMedical Center between July 2008 and January 2009. The
Institutional ReviewBoard (The IRB approval number is 00195)
reviewed the protocol and approved the study. All subjects
signed the informed consent. All subjects were evaluated by
a physician and a list of symptoms, co-morbidities and current
medications were documented. For the patients with COPD,
the inclusioncriteriawereage40orolder,historyofat least10
pack/years of smoking. Exclusion criteria included recent
COPD exacerbation (within 2 months) myocardial infarction
(less than 6 months), uncontrolled hypertension, angina, or
neuro-muscular conditions that would interfere with the
tests. The healthy age-matched control subjects were
volunteers recruited through advertisement in our hospital.
They underwent an evaluation by a physician to ensure that
they were free from significant pulmonary or cardiac disease.
Specifically, patients with any degree of edema, increased
jugular vein distention, hepato-jugular reflux, lung rales or
ECG findings of right ventricular strain or cardiomegaly on
chest X-ray were excluded.
Physiological measurements
Patients performed pulmonary function test following ATS/
ERS guidelines.11 The CPET was performed following ATS/
ACCP standards.12 In short, patients performed exercise
using a cycle ergometer and gas exchange was measured
using a metabolic cart (V Max Sensormedic, Yorba Linda
CA). The protocol included 3 stages: Resting (2 min dura-
tion, with the subject sitting up, and not pedaling), warm
up (3 min duration, unloading pedaling - no resistance;
pedaling at a rate of 60 cycles per minute) and a symptom
limited exercise that was completed encouraging patients
to reach exhaustion. Work was increased at a rate of 16 W
per minute. During every stage, the oxygen uptake (VO2),
carbon dioxide production (VCO2), heart rate (12-lead
electrocardiogram), respiratory rate and tidal volume (Vt)
were measured. The patients were encouraged to cycle to
the point of discomfort or exhaustion. The test was inter-
rupted if an abnormal electrocardiogram, a systolic blood
pressure 220 mmHg or diastolic blood pressure 120 mmHg
was measured. Arterial blood gas was collected from the
radial artery before and immediately after the CPET. All
exercise parameters were calculated using the formulas
described by Wasserman et al.13
The maximal grip strength for each hand was averaged
from three measurements, at rest, made with the hand
unsupported, with the elbow at 90 flexion, underarm and
wrist inneutral positionusingadynamometer (Jamar;Asimow
Engineering Co; Santa Monica CA).14 Maximum inspiratory
mouth pressures (PImax) from residual volume (RV) and
maximumexpiratorymouthpressures (PEmax) fromtotal lung
capacity (TLC) were measured according to the method
described by Black and Hyatt.15 Measurements were obtained
in the sitting position. Five maneuvers were performed and
reproducibility at 5e10per centand thehighest valueused for
the calculations.16
Maximal voluntary ventilation (MVV) was obtained in the
sitting position, breathing deeply and fast for 12 s. The
subjects were encouraged to maintain the same volume
and frequency. At least two acceptable maneuvers (with no
more than a 10% difference between them) were obtained.
The highest value was recorded.
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Height and weight were measured with the patient standing
barefoot in light clothing. The body mass index (BMI) was
calculated as weight/height.2 The fat free mass (FFM) was
measured using bioelectrical impedance (Bodystat 1500 v
2/02, Bodystat Limited, British Isles). Resistance was
measured in supine position at the right side as described
by Lukaski et al.17
Statistical analysis
Data are shown as mean and standard deviation. Differences
were compared using student’s t-test for independent vari-
ables and ManneWhitney U-statistic. The strength of the
association among the variables related to muscle function
and exercise capacitywas explored calculating the Pearson’s
productemoment correlation coefficient. Proportions were
compared using Fisher’s exact test. Simple linear regressions
were also performed considering as dependent those vari-
ables associatedwith exercise capacity. Iso timewas defined
as that point during the exercise that was common for all
subjects. The level of statistical significance for each test
was p < 0.05. Analysis was performed using a commercially
available statistics package The SPSS version 16.0 statistical
software was used for data analysis (SPSS, Chicago, IL).Results
General characteristics of the entire group are presented in
Table 1. Patients and controls were similar in age, height,
weight, BMI (COPD 27.3  4 and control 26.4  2) kg/m2 and
FFM (COPD 62  10 and control 65.4  6) kg. As expected,
the COPD patients had significantly (p < 0.01) lower valuesTable 1 General characteristics of the patients with COPD and
COPD n Z 18
Age (yr) 64.3 (9.7)
Height (m) 1.76 (0.0)
Weight (Kg) 85 (16)
BMI (Kg/m2) 27.3 (4.8)
FFM (% of body mass) 62.0 (10.5)
FEV1 (L post) 1.51 (0.73)
FEV1 (%post) 44.8 (20.4)
FEV1/FVC post 43.6 (13.5)
MVV 96.7 (22.2)
DLCO (%pred) 64.5 (17.4)
IC (L) 2.83 (1.0)
TLC (L) 8.60 (1.63)
Pack year 53.1 (21.4)
SpO2% 93.7 (3.3)
Pimax (cmH2O) 79.2 (24.4)
Pemax (cmH2O) 59.5 (16.1)
Handgrip (Kg force) 37.8 (7.5)
MMRC (dyspnea score) 1.2 (0.4)
BMI Z body mass index; FFM Z fat-free mass; FEV1 Z forced ex
DLCO Z single-breath diffusing capacity for carbon monoxide; IC Z
saturation; PimaxZ maximal inspiratory capacity; PemaxZ maxima
dyspnea scale.of IC (COPD 2.83  1 and control 3.44  0.4) L, PiMax (COPD
79.2  24 and control 108  12) cmH2O, and handgrip force
(COPD 37.8  7 and control 55  2) kg. The COPD patients
presented moderate to very-severe airflow obstruction
(FEV1 44.8  20.4%).
Table 2 shows the values of the exercise test components
between COPD patients and controls at rest and peak exer-
cise. Compared with controls at rest, the COPD patients had
significantly higher heart rate (COPD 76  11 and controls
61  5, bpm) and lower oxygen pulse mL/beat (COPD
5.22  1.50 and control 6.82  0.82). With exercise, COPD
patients had lower peak VO2 L/min (COPD 1.1  0.3 and
control 1.72 0.4), peak VO2 inml/Kg/min (COPD 14.6 5.3
and control 21.2  7.9), O2 pulse ml/beat (COPD 10.6  3.7
and control 14.3  2.7), maximal work (Watts) achieved
(COPD 79.6  36.9 and control 143.2  31.7) and heart rate
beats/min (COPD 112  14 and control 147  18). The
difference inoxygenpulseduringexercisepersistedbetween
COPD patients and the control group evenwhen corrected by
differences in muscle mass (O2 pulse/Kg of FFM) (COPD was
0.171  0.01 and control 0.219  0.01, p < 0.001). The
baseline PaO2 was 76.7  8 mmHg and increased with exer-
cisewith a peak PaO2 value of 83.6 9.5mmHg. The baseline
PaCO2 41.7 6 increasedminimally to peak PaCO2 43.6 6.8
(data not shown in the table). The baseline SpO2 was
93.7  3% and at the end of the exercise was 95%.
Associations
There was a significant inverse association in patients and
controls between resting heart rate and handgrip strength
(r Z  0.75, p < 0.0001) as shown in Fig. 1. There were
significant associations between handgrip strength and
respiratory muscle strength as well as with the IC and DLCO
as shown in Table 3.controls included in the study.
CONTROL n Z 15 p value
61.6 (7.7) 0.3872
1.72 (0.0) 0.0786
78 (12) 0.1640
26.4 (2.6) 0.6513
65.4 (6.1) 0.4160
3.02 (0.67) < 0.0001
99.0 (16.8) < 0.0001
81.4 (16.1) < 0.0001
108.8 (22.6) 0.1367
98.3 (8.6) < 0.0001
3.44 (0.4) 0.0250
6.44 (1.55) 0.0005
0
96.2 (1.0) 0.0144
108.0 (12.4) 0.0011
121.4 (24.2) < 0.0001
55.0 (2.8) < 0.0001
0.0 (0.2) < 0.0001
piratory volume in 1 s; MVV Z maximal voluntary ventilation;
inspiratory capacity; TLC Z total lung capacity; SpO2 Z oxygen
l expiratory capacity; MMRCZ modified medical research council
Table 2 Response to exercise in the patients and controls included in the study.
COPD n Z 18 CONTROL n Z 15 p value
Duration CPET (min) 5.1 (2.22) 10.2 (1.22) < 0.0001
Max workload (Watts) 79.6 (36.9) 143.2 (31.7) < 0.0001
Max VO2 (L/min) 1.10 (0.38) 1.72 (0.47) 0.0003
Max VO2 (mL/Kg/min) 14.6 (5.3) 21.2 (7.9) 0.0077
Heart rate baseline (beats/min) 76 (12) 62 (6) < 0.0001
Max HR (beats/min) 113 (15) 148 (18) < 0.0001
Baseline O2 pulse (mL/beat) 5.22 (9.5) 6.82 (0.8) 0.0133
Max O2 pulse (mL/beat) 10.6 (3.7) 14.3 (2.7) 0.0031
IC baseline (L) 2.29 (0.73) 2.93 (0.80) 0.0327
IC peak (L) 1.79 (0.62) 2.92 (1.00) 0.0005
Max VO2 (L/min/Kg of FFM) 0.020 (0.00) 0.026 (0.00) 0.0200
Max O2 pulse (mL/beat/Kg of FFM) 0.171 (0.05) 0.219 (0.03) 0.0033
CPET Z cardiopulmonary exercise test; VO2 Z maximal oxygen consumption; AT Z anaerobic threshold; HR Z heart rate;
IC Z inspiratory capacity.
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suggests the presence of patients with higher and lower grip
force, the COPD patients were then divided arbitrarily in two
groups: lower handgrip <38 kg force (n Z 11) and higher
handgrip  38 kg (nZ 7). The general characteristics of the
two groups are described in Table 4. The group of COPD
patient with handgrip<38 kg force when compared with the
other group had similar airflow obstruction ehowever the
lower handgrip group had significantly (p < 0.01) lower MVV
(87.7  23.8 and 109.5  11.8), IC (2.45  0.88 and
3.43 0.93), andTLC (7.851.41 and9.801.21). They also
had a shorter duration in their CPET (4 1.5 and 7 2.1min),
lower peak VO2 L/min (1.03  0.3 and 1.62  0.6), peak
VO2 mL/Kg/min (12.5  3.7 and 17.9  6.0), O2 pulse
mL/beat (9.11  2.4 and 13.01  4.2), and higher baseline
heart rate (81.5  11.8 and 69.0  6.2) and lower FFM
(57.9 9.6 and 68.6 9.0) respectively. The reasons to stop
the exercise (dyspnea, leg fatigue or both) were similar in
both groups. Therewere no differences inmedications taken
by either group.
Fig. 2, shows the resting and exercise isotime VO2 (panel
a) and its determinants, the heart rate (panel b) andFigure 1 There was an inverse association between heart
rate and handgrip force in man with chronic obstructive
pulmonary disease (n Z 18) and age, gender match controls
(n Z 15). Chronic obstructive pulmonary disease () and
control group (B). A significant correlation was found
(r Z 0.7492; p < 0.0001).oxygen pulse (panel c) in patients classified according to
the handgrip strength. Patients with <38 kg had signifi-
cantly lower oxygen pulse primarily due to a higher heart
rate and slightly lower oxygen uptake at all time points.
The difference disappeared when the COPD groups are
corrected by the muscle mass as we can see in Fig. 3.Discussion
The most important and novel finding in the present study is
the direct association between handgrip strength at rest and
impaired cardiac function as determined with the oxygen
pulse at rest and during exercise in patients with COPD. This
difference was not due to the muscle mass between COPD
and controls because it persisted when the oxygen pulse was
corrected by fat free mass. In addition, our findings suggest
that COPD has systemic manifestations affecting both
muscles groups independent of fat free mass.
A strong association between handgrip strength and
oxygen pulse in patients with COPD was first described by
Vassaux et al. in a group of 87 patients with severe and very-
severe airflow obstruction (FEV1Z 34  14%). In that study,
resting lung hyperinflation was associated with an impaired
oxygen pulse during exercise, but the association between
handgrip force and the oxygen pulse was significant and even
stronger than that observed between hyperinflation and
oxygen pulse in the multivariate analysis,3 suggesting that
the relationship was not just due to hyperinflation per-se.
The association between heart function and handgrip
strength independent of lung hyperinflation is supported by
similar observation that have been reported in patients with
CHF.14 In patients with heart failure without COPD, handgrip
force has been shown to be a strong and independent
predictor of exercise capacity and degree of functional
impairment as classified by the New York Heart Association.8
We were intrigued about the nature of the association
between handgrip force and cardiac function in COPD and
CHF and hypothesized that reduced handgrip strength
relates to muscle weakness, which could include the heart.
This hypothesis has some empirical observations to support
it. It is known that there is a significant relationship between
handgrip strength and the strength of other peripheral
Table 3 Associations between heart rate, oxygen pulse, handgrip force and physiological variables.
FEV1 % DLCO IC/TLC FFM BMI Pimax Handgrip IC FVC MVV
Heart rate 0.2171 0.4521 0.3190 0.1566 0.1320 0.2816 0.6245* 0.4513 0.4705 0.2433
O2 pulse 0.5068* 0.6992* 0.7654* 0.4616 0.2816 0.2899 0.6709* 0.8059* 0.7738* 0.0541
Handgrip 0.0063 0.2814 0.5697* 0.5835* 0.0016 0.4073 e 0.5822* 0.4160 0.4563
FEV1 Z forced expiratory volume in 1 s; DLCO Z single-breath diffusing capacity for carbon monoxide; IC Z inspiratory capacity;
TLC Z total lung capacity; FFM Z fat-free mass; BMI Z body mass index; Pimax Z maximal inspiratory capacity. *: p < 0.001.
752 F. Cortopassi et al.muscles as evaluated by the elbow flexion, knee and flexor
strength.18 In our study, there was a significant association
between handgrip strength, maximal inspiratory muscle
pressure, inspiratory capacity, forced vital capacity and
maximal voluntary ventilation (Table 3) all maneuvers that
reflect respiratory muscle strength. Several large population
studies have shown that handgrip strength is a strongTable 4 Clinical and physiological characteristics of the patient
details).
HG< 38 kg nZ 1
Age (yr) 63.2 (9.6)
Height (cm) 1.78 (0.05
Weight (Kg) 82.9 (18.3)
MVV 87.7 (23.8)
DLCO (%pred) 60.3 (12.4)
Pimax (cmH2O) 71.6 (21.1)
Pemax (cmH2O) 57.4 (18.1)
IC (L) 2.45 (0.88
TLC (L) 7.85 (1.41
IC/TLC (L) 0.31 (0.1)
Pack year 51.1 (14.7)
Duration CPET (min) 4 (2)
Max VO2 (L/min) 1.03 (0.3)
Max VO2 (mL/Kg/min) 12.5 (3.7)
AT (L/min) 0.86 (0.2)
Heart rate baseline (beats/
min)
81.5 (11.8)
Max heart rate (beats/min) 113.0 (18.0)
Max O2 pulse (mL/beat) 9.11 (2.4)
SpO2% 93.5 (3.7)
IC baseline (L) 1.92 (0.6)
IC peak (L) 1.61 (0.6)
Handgrip (Kg) 32.4 (2.3)
Work (Watts) 63.0 (28.8)
BMI (Kg/m2) 27.7 (5.6)
FFM (Kg) 57.9 (9.6)
Max VO2 (L/min/FFM) 0.017 (0.0
Max O2 pulse (mL/beat/Kg of
FFM)
0.159 (0.0
Beta agonists (%) 100
Inhaled corticosteroids (%) 36.3
Systemic corticosteroids (%) 18.1
Theophylline (%) 9.0
Tiotropium bromide (%) 63.6
HG Z handgrip; BMI Z body mass index; FFM Z fat-free mass; FEV
ventilation; DLCO Z single-breath diffusing capacity for carbon mo
SpO2 Z oxygen saturation; Pimax Z maximal inspiratory capacity;
VO2 Z maximal oxygen consumption; AT Z anaerobic threshold; HRindependent predictor of mortality.18e20 Rantanen et al.18
studied 919 women ranging in age from 65 to 101 years and
followed them over 5 years. Handgrip strength was a power-
ful predictor of all cause, cardiovascular and respiratory
mortality evenwhen adjusted formultiple diseases, physical
inactivity, smoking, unintentional weight loss, depression
and even levels of interleukin-6, serum albumin and C-s with COPD classified by handgrip force of 38 kg (see text for
1 HG 38 kg nZ 7 p value
66.1 (10.3) 0.5580
) 1.82 (0.04) 0.0679
88.8 (12.0) 0.4605
109.5 (11.8) 0.0420
71.1 (22.8) 0.1891
91.2 (26.0) 0.0978
62.7 (13.0) 0.5180
) 3.43 (0.93) 0.0400
) 9.80 (1.21) 0.0084
0.35 (0.1) 0.3459
56.1 (26.1) 0.8919
7 (2) 0.0087
1.62 (0.6) 0.0197
17.9 (6.0) 0.0318
1.18 (0.5) 0.1806
69.0 (6.2) 0.0207
111.7 (7.6) 0.7242
13.01 (4.2) 0.0244
94.1 (3.0) 0.7271
2.86 (0.6) 0.0080
2.07 (0.4) 0.1312
46.2 (3.9) < 0.0001
105.7 (34.4) 0.0119
26.6 (3.6) 0.6618
68.6 (9.0) 0.0318
0) 0.023 (0.00) 0.1124
0) 0.190 (0.00) 0.2107
85.7 0.8146
85.7 0.1170
28.5 0.6052
14.2 0.8146
71.4 0.7324
1 Z forced expiratory volume in 1 s; MVV Z maximal voluntary
noxide; IC Z inspiratory capacity; TLC Z total lung capacity;
Pemax Z maximal expiratory capacity; BP Z blood pressure;
Z heart rate.
Figure 2 The oxygen uptake (panel A), heart rate (panel B)
and oxygen pulse (panel C) at baseline, warm-up, minutes one,
two and three during exercise were different between patients
with lower hand grip force (closed circle) and higher hand grip
force (closed square). *: p < 0.001.
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findings. Sasaki et al. in Japan19 reported on a cohort of 4912
persons (1695 men and 3217 women) between the ages of
35e74 years, followed for 29 years. In that cohort, handgrip
strengthwas a strong predictor ofmortality especially due to
heart disease and stroke. Every increase of 5 kg of force was
associated with an 18% (95% CI 25, 9) decrease in the risk of
death from heart disease. Gale and co-workers in the United
Kingdom20 studied 800 persons older than 65 years and
determined the cause of death over 24 years. Poorer hand-
grip strength was associated with increased mortality fromFigure 3 The oxygen pulse corrected by fat free mass was
similar in patients with low or high handgrip force.all causes, cardiovascular disease and cancer in men. Inter-
estingly, in that study the findings persisted when the asso-
ciationwasadjustedbypotential confounding factors suchas
arm muscle area, BMI, fat free mass or % of fat.
In addition, a body of literature links handgrip strength
with heart function in patients with heart failure. Izawa
et al. 8 showed in a cross-sectional study of 107 patients
with congestive heart failure, that the NYHA functional
class increased as VO2 peak, grip strength, and knee
extensor and flexor muscle strength decreased in these
patients. Also, in that study stepwise linear regression
analysis revealed that grip strength and knee extensor
strength were significant in predicting the VO2 peak. In
another study, reduced handgrip strength was also docu-
mented in patients with heart failure carefully selected to
exclude other illnesses including respiratory diseases.8
In our study, patients with COPD presented the same
relation between handgrip force and heart impairment than
that reported for patients with heart failure. We found that
at rest, patients with COPD had a lower handgrip strength
and higher heart rate compared with controls that was not
related to the presence of clinical heart disease. The
results are not explained by the use of cardiac medications,
because this was similar between the two groups. When the
COPD group was analyzed separately, the relationship
between handgrip force and heart rate was still present so
that the lower the handgrip force the higher the heart rate.
Again, this was not due to medications because as shown in
Table 4, the use of medications that can influence heart
rate was similar in the two groups of patients with COPD.
The exact nature and reason for the presence of decreased
muscle strength in patients with COPD and those with heart
failure isunclear. PatientswithCOPDaswell asCHF frequently
suffer skeletal muscle atrophy, altered muscle metabolism,
and reduced mitochondrial-based enzyme levels, all factors
that could lead to decreased muscle force. In COPD and
chronic heart failure, oxygen delivery to peripheral and
respiratorymusclesmay be deficient as a result of hypoxemia,
reduced blood supply, or both. In either case, muscle tissue
maybehypoxicand this could lead to themaladaptive changes
in skeletalmuscle. It is tempting to speculate that the heart (a
muscle after all) like the peripheral muscles in COPD and CHF
patients is affected by the same systemic effects leading to
heart weakness and dysfunction.21e23
Our study has some limitations: First is the lack of direct
measurement of the cardiac output using a pulmonary artery
catheter. However, the latter is an invasive measurement
that does not exclude complications and is technically
difficult to perform during exercise. Several studies support
the validity of the oxygen pulse as a surrogate marker of
stroke volume in patients with COPD and the changes
observed in heart rate are consistent with our findings. A
second limitation is the enrollment of only male patients in
the current study. We cannot assume that the same inter-
action between peripheral muscle weakness and cardiac
impairment happens in females. On the other hand the
recruitment of men was intentional, so that the effect of
gender on body composition would not influence the results.
Third, we did not measure lower extremity force; however,
handgrip strength is closely related to lower extremity
force. Furthermore, we did include respiratory muscle
strength, which has been shown to be associated with
754 F. Cortopassi et al.severity of airflow obstruction and functional dyspnea as
measured with the MRC scale in patients with COPD.24
In conclusion, the present study shows that impaired
handgrip force at rest is associated with impaired heart
function as expressed by the oxygen pulse at rest and
during exercise in patients with COPD even when the
response is corrected for muscle mass differences and lung
inflation. This suggests a synchronous dysfunction of the
heart and other skeletal muscles in some patients with
COPD that is not only due to lung mechanics. This rela-
tionship needs to be further explored so that appropriate
management of therapies may be optimized.
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